Trytosaveabit commented on a stock · May 25 06:31

Going through my notes here this morning! Decided I would share so you to can make a note. That’s if you wish!

$HOOKIPA Pharma(HOOK.US)$ First though there is to be additional data come out of the ASCO June 4th! Also Researchers intend to present data from investigator initiated trial of HB-200 W/Chemo, on June 3RD! And now to what i wanted to share from my notes that i took in January! Anticipated Milestones

● Phase 2 HB-200 in HPV16+ head and neck cancers o 1st-line follow-up data in combination with pembrolizumab: H1 2024 o Start of 1st-line randomized study in combination with pembrolizumab: mid-2024 (Fast Track designation)

● Phase 1 HB-300 in prostate cancer o Preliminary safety and immunogenicity data: H1 2024

● HB-700 in KRAS-mutated cancers: IND filing H1 2024

● HB-400 in hepatitis B: to be determined by Gilead

● HB-500 in HIV: IND filing Q4 2023

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more